Therefore, it is likely that the direct impact of nucleoside drugs on hematopoietic precursors, the indirect impact on the loss of endogenous function of NTs, and the altered functional consequences of nucleoside transporter variants on nucleoside analogs may be significant players in clinically observed hematological toxicities [ Figure 2 ].
← all excerpts
Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective.
1
—
—